BCL2
Genomic MapAssay Details
| Gene Symbol: BCL2 | ||||||
|---|---|---|---|---|---|---|
| Interrogated Sequence | Translated Protein | Exon Boundary | Assay Location | IMAGE Clone ID | Amplicon Length | |
| RefSeq | NM_000633.2 | NP_000624.2 | 2 | 459 | 130 | |
| NM_000657.2 | NP_000648.2 | 2 | 459 | 130 | ||
| XM_011526135.2 | XP_011524437.1 | 1 | 1078 | 130 | ||
| XM_017025917.1 | XP_016881406.1 | 2 | 857 | 130 | ||
| GenBank mRNA | BC027258.1 | - | 2 | 355 | 4511027 | 130 |
| M13994.1 | - | 1 | 1424 | 130 | ||
| M13995.1 | - | 1 | 112 | 130 | ||
Back To TopMore Information
Updated Mapping Information
This assay targets the same location as Clariom D transcript cluster(s) TC1800008891.hg.1This assay targets the same location as HTA transcript cluster(s) TC18000554.hg.1
Additional Information:
This assay is in the 5'UTR region of the BC027258.1, M13994.1, M13995.1, NM_000633.2, NM_000657.2, XM_011526135.2, XM_017025917.1 transcripts.
Set Membership: |
Ambion siRNA available
Amplicon length greater than or equal to 101
Immune Tolerance Network
Mammalian Gene Collection
Detect Genomic DNA
Homo sapiens
1700
Inventoried
Both primers and probe map within a single exon
|
Matching Ambion siRNAs:
Gene Ontology Categories:
Function(s)
Process(es)
protein polyubiquitination
ossification
ovarian follicle development
metanephros development
branching involved in ureteric bud morphogenesis
behavioral fear response
B cell homeostasis
release of cytochrome c from mitochondria
regulation of cell-matrix adhesion
lymphoid progenitor cell differentiation
B cell lineage commitment
response to ischemia
renal system process
protein dephosphorylation
melanin metabolic process
regulation of nitrogen utilization
apoptotic process
humoral immune response
cellular response to DNA damage stimulus
actin filament organization
axonogenesis
female pregnancy
cell aging
male gonad development
extrinsic apoptotic signaling pathway via death domain receptors
intrinsic apoptotic signaling pathway in response to DNA damage
intrinsic apoptotic signaling pathway in response to oxidative stress
response to radiation
response to xenobiotic stimulus
response to toxic substance
post-embryonic development
response to iron ion
response to UV-B
response to gamma radiation
regulation of gene expression
negative regulation of autophagy
negative regulation of calcium ion transport into cytosol
regulation of glycoprotein biosynthetic process
mesenchymal cell development
positive regulation of neuron maturation
positive regulation of smooth muscle cell migration
cell growth
peptidyl-serine phosphorylation
peptidyl-threonine phosphorylation
cochlear nucleus development
gland morphogenesis
regulation of transmembrane transporter activity
negative regulation of ossification
positive regulation of cell growth
negative regulation of cell growth
melanocyte differentiation
negative regulation of cell migration
positive regulation of B cell proliferation
hair follicle morphogenesis
axon regeneration
regulation of protein stability
endoplasmic reticulum calcium ion homeostasis
glomerulus development
negative regulation of cellular pH reduction
negative regulation of myeloid cell apoptotic process
T cell differentiation in thymus
positive regulation of peptidyl-serine phosphorylation
negative regulation of osteoblast proliferation
response to cytokine
response to nicotine
organ growth
positive regulation of multicellular organism growth
B cell proliferation
cellular response to glucose starvation
response to hydrogen peroxide
T cell homeostasis
negative regulation of apoptotic process
positive regulation of catalytic activity
CD8-positive, alpha-beta T cell lineage commitment
regulation of protein homodimerization activity
regulation of protein heterodimerization activity
negative regulation of neuron apoptotic process
ear development
regulation of viral genome replication
positive regulation of melanocyte differentiation
negative regulation of retinal cell programmed cell death
regulation of mitochondrial membrane permeability
focal adhesion assembly
spleen development
thymus development
digestive tract morphogenesis
oocyte development
positive regulation of skeletal muscle fiber development
pigment granule organization
homeostasis of number of cells within a tissue
B cell receptor signaling pathway
response to glucocorticoid
neuron apoptotic process
defense response to virus
regulation of mitochondrial membrane potential
negative regulation of mitochondrial depolarization
regulation of calcium ion transport
transmembrane transport
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress
cellular response to organic substance
cellular response to hypoxia
reactive oxygen species metabolic process
extrinsic apoptotic signaling pathway in absence of ligand
positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway
negative regulation of G1/S transition of mitotic cell cycle
negative regulation of reactive oxygen species metabolic process
negative regulation of anoikis
negative regulation of apoptotic signaling pathway
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
negative regulation of intrinsic apoptotic signaling pathway
positive regulation of intrinsic apoptotic signaling pathway
protease binding
protein binding
transcription factor binding
channel activity
channel inhibitor activity
ubiquitin protein ligase binding
identical protein binding
protein homodimerization activity
sequence-specific DNA binding
protein heterodimerization activity
BH3 domain binding
protein phosphatase 2A binding
protein polyubiquitination
ossification
ovarian follicle development
metanephros development
branching involved in ureteric bud morphogenesis
behavioral fear response
B cell homeostasis
release of cytochrome c from mitochondria
regulation of cell-matrix adhesion
lymphoid progenitor cell differentiation
B cell lineage commitment
response to ischemia
renal system process
protein dephosphorylation
melanin metabolic process
regulation of nitrogen utilization
apoptotic process
humoral immune response
cellular response to DNA damage stimulus
actin filament organization
axonogenesis
female pregnancy
cell aging
male gonad development
extrinsic apoptotic signaling pathway via death domain receptors
intrinsic apoptotic signaling pathway in response to DNA damage
intrinsic apoptotic signaling pathway in response to oxidative stress
response to radiation
response to xenobiotic stimulus
response to toxic substance
post-embryonic development
response to iron ion
response to UV-B
response to gamma radiation
regulation of gene expression
negative regulation of autophagy
negative regulation of calcium ion transport into cytosol
regulation of glycoprotein biosynthetic process
mesenchymal cell development
positive regulation of neuron maturation
positive regulation of smooth muscle cell migration
cell growth
peptidyl-serine phosphorylation
peptidyl-threonine phosphorylation
cochlear nucleus development
gland morphogenesis
regulation of transmembrane transporter activity
negative regulation of ossification
positive regulation of cell growth
negative regulation of cell growth
melanocyte differentiation
negative regulation of cell migration
positive regulation of B cell proliferation
hair follicle morphogenesis
axon regeneration
regulation of protein stability
endoplasmic reticulum calcium ion homeostasis
glomerulus development
negative regulation of cellular pH reduction
negative regulation of myeloid cell apoptotic process
T cell differentiation in thymus
positive regulation of peptidyl-serine phosphorylation
negative regulation of osteoblast proliferation
response to cytokine
response to nicotine
organ growth
positive regulation of multicellular organism growth
B cell proliferation
cellular response to glucose starvation
response to hydrogen peroxide
T cell homeostasis
negative regulation of apoptotic process
positive regulation of catalytic activity
CD8-positive, alpha-beta T cell lineage commitment
regulation of protein homodimerization activity
regulation of protein heterodimerization activity
negative regulation of neuron apoptotic process
ear development
regulation of viral genome replication
positive regulation of melanocyte differentiation
negative regulation of retinal cell programmed cell death
regulation of mitochondrial membrane permeability
focal adhesion assembly
spleen development
thymus development
digestive tract morphogenesis
oocyte development
positive regulation of skeletal muscle fiber development
pigment granule organization
homeostasis of number of cells within a tissue
B cell receptor signaling pathway
response to glucocorticoid
neuron apoptotic process
defense response to virus
regulation of mitochondrial membrane potential
negative regulation of mitochondrial depolarization
regulation of calcium ion transport
transmembrane transport
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress
cellular response to organic substance
cellular response to hypoxia
reactive oxygen species metabolic process
extrinsic apoptotic signaling pathway in absence of ligand
positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway
negative regulation of G1/S transition of mitotic cell cycle
negative regulation of reactive oxygen species metabolic process
negative regulation of anoikis
negative regulation of apoptotic signaling pathway
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
negative regulation of intrinsic apoptotic signaling pathway
positive regulation of intrinsic apoptotic signaling pathway
protease binding
protein binding
transcription factor binding
channel activity
channel inhibitor activity
ubiquitin protein ligase binding
identical protein binding
protein homodimerization activity
sequence-specific DNA binding
protein heterodimerization activity
BH3 domain binding
protein phosphatase 2A binding
MicroArray Probes:
Affymetrix
ABI
| Array Name | Probe IDs | Targets | Target Type |
|---|---|---|---|
| Affymetrix Human Transcriptome Array 2.0 | PSR18005761.hg.1 | ENST00000444484.1 | Ensembl |
| Affymetrix Human Transcriptome Array 2.0 | PSR18005761.hg.1 | NM_000657.2 | Refseq |
| Affymetrix Human Transcriptome Array 2.0 | PSR18005761.hg.1 | TC18000554.hg.1 | HTA TC |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | ENST00000333681.4 | Ensembl |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | ENST00000333681.4 | Ensembl |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | ENST00000333681.4 | Ensembl |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | ENST00000333681.4 | Ensembl |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | ENST00000333681.4 | Ensembl |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | ENST00000333681.4 | Ensembl |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | ENST00000333681.4 | Ensembl |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | ENST00000333681.4 | Ensembl |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | ENST00000333681.4 | Ensembl |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | ENST00000398117.1 | Ensembl |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | ENST00000398117.1 | Ensembl |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | ENST00000398117.1 | Ensembl |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | ENST00000398117.1 | Ensembl |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | ENST00000398117.1 | Ensembl |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | ENST00000398117.1 | Ensembl |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | ENST00000398117.1 | Ensembl |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | ENST00000398117.1 | Ensembl |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | ENST00000398117.1 | Ensembl |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | ENST00000398117.1 | Ensembl |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | ENST00000398117.1 | Ensembl |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | ENST00000398117.1 | Ensembl |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | ENST00000589955.1 | Ensembl |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | ENST00000589955.1 | Ensembl |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | ENST00000589955.1 | Ensembl |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | ENST00000589955.1 | Ensembl |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | ENST00000589955.1 | Ensembl |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | ENST00000590515.1 | Ensembl |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | ENST00000590515.1 | Ensembl |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | NM_000633.2 | Refseq |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | NM_000633.2 | Refseq |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | NM_000633.2 | Refseq |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | NM_000633.2 | Refseq |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | NM_000633.2 | Refseq |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | NM_000633.2 | Refseq |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | NM_000633.2 | Refseq |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | NM_000633.2 | Refseq |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | NM_000633.2 | Refseq |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | NM_000657.2 | Refseq |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | NM_000657.2 | Refseq |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | NM_000657.2 | Refseq |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | NM_000657.2 | Refseq |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | NM_000657.2 | Refseq |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | NM_000657.2 | Refseq |
| Affymetrix Human Transcriptome Array 2.0 | TC1800008891.hg.1 | NM_000657.2 | Refseq |
| Affymetrix Human Transcriptome Array 2.0 | PSR18005762.hg.1 | ENST00000333681.3 | Ensembl |
| Affymetrix Human Transcriptome Array 2.0 | PSR18005762.hg.1 | ENST00000398117.1 | Ensembl |
| Affymetrix Human Transcriptome Array 2.0 | PSR18005762.hg.1 | ENST00000444484.1 | Ensembl |
| Affymetrix Human Transcriptome Array 2.0 | PSR18005762.hg.1 | NM_000633.2 | Refseq |
| Affymetrix Human Transcriptome Array 2.0 | PSR18005762.hg.1 | NM_000657.2 | Refseq |
| Affymetrix Human Transcriptome Array 2.0 | PSR18005762.hg.1 | TC18000554.hg.1 | HTA TC |
| Affymetrix Human Transcriptome Array 2.0 | PSR18005760.hg.1 | ENST00000444484.1 | Ensembl |
| Affymetrix Human Transcriptome Array 2.0 | PSR18005760.hg.1 | NM_000657.2 | Refseq |
| Affymetrix Human Transcriptome Array 2.0 | PSR18005760.hg.1 | TC18000554.hg.1 | HTA TC |
| Affymetrix Human Clariom D Assay | PSR1800161107.hg.1 | ENST00000333681.4 | Ensembl |
| Affymetrix Human Clariom D Assay | PSR1800161107.hg.1 | ENST00000398117.1 | Ensembl |
| Affymetrix Human Clariom D Assay | PSR1800161107.hg.1 | ENST00000589955.1 | Ensembl |
| Affymetrix Human Clariom D Assay | PSR1800161107.hg.1 | NM_000633.2 | Refseq |
| Affymetrix Human Clariom D Assay | PSR1800161107.hg.1 | NM_000657.2 | Refseq |
| Affymetrix Human Clariom D Assay | PSR1800161107.hg.1 | TC1800008891.hg.1 | Clariom D TC |
| Affymetrix Human Clariom D Assay | PSR1800161107.hg.1 | NM_000633.2 | Refseq |
| Affymetrix Human Clariom D Assay | PSR1800161107.hg.1 | ENST00000333681.4 | Ensembl |
| Affymetrix Human Clariom D Assay | PSR1800161107.hg.1 | ENST00000398117.1 | Ensembl |
| Affymetrix Human Clariom D Assay | PSR1800161107.hg.1 | ENST00000589955.1 | Ensembl |
| Affymetrix Human Clariom D Assay | PSR1800161107.hg.1 | NM_000657.2 | Refseq |
| Affymetrix Human Clariom D Assay | PSR1800161108.hg.1 | ENST00000333681.4 | Ensembl |
| Affymetrix Human Clariom D Assay | PSR1800161108.hg.1 | ENST00000398117.1 | Ensembl |
| Affymetrix Human Clariom D Assay | PSR1800161108.hg.1 | ENST00000589955.1 | Ensembl |
| Affymetrix Human Clariom D Assay | PSR1800161108.hg.1 | NM_000633.2 | Refseq |
| Affymetrix Human Clariom D Assay | PSR1800161108.hg.1 | NM_000657.2 | Refseq |
| Affymetrix Human Clariom D Assay | PSR1800161108.hg.1 | TC1800008891.hg.1 | Clariom D TC |
| Affymetrix Human Clariom D Assay | PSR1800161108.hg.1 | ENST00000333681.4 | Ensembl |
| Affymetrix Human Clariom D Assay | PSR1800161108.hg.1 | ENST00000398117.1 | Ensembl |
| Affymetrix Human Clariom D Assay | PSR1800161108.hg.1 | ENST00000589955.1 | Ensembl |
| Affymetrix Human Clariom D Assay | PSR1800161108.hg.1 | NM_000633.2 | Refseq |
| Affymetrix Human Clariom D Assay | PSR1800161108.hg.1 | NM_000657.2 | Refseq |
| Affymetrix Human Clariom D Assay | PSR1800161106.hg.1 | ENST00000589955.1 | Ensembl |
| Affymetrix Human Clariom D Assay | PSR1800161106.hg.1 | NM_000657.2 | Refseq |
| Affymetrix Human Clariom D Assay | PSR1800161106.hg.1 | TC1800008891.hg.1 | Clariom D TC |
| Affymetrix Human Clariom D Assay | PSR1800161106.hg.1 | ENST00000589955.1 | Ensembl |
| Affymetrix Human Clariom D Assay | PSR1800161106.hg.1 | NM_000657.2 | Refseq |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | ENST00000333681.4 | Ensembl |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | ENST00000333681.4 | Ensembl |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | ENST00000333681.4 | Ensembl |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | ENST00000333681.4 | Ensembl |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | ENST00000333681.4 | Ensembl |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | ENST00000333681.4 | Ensembl |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | ENST00000333681.4 | Ensembl |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | ENST00000333681.4 | Ensembl |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | ENST00000333681.4 | Ensembl |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | ENST00000398117.1 | Ensembl |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | ENST00000398117.1 | Ensembl |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | ENST00000398117.1 | Ensembl |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | ENST00000398117.1 | Ensembl |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | ENST00000398117.1 | Ensembl |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | ENST00000398117.1 | Ensembl |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | ENST00000398117.1 | Ensembl |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | ENST00000398117.1 | Ensembl |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | ENST00000398117.1 | Ensembl |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | ENST00000398117.1 | Ensembl |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | ENST00000398117.1 | Ensembl |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | ENST00000398117.1 | Ensembl |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | ENST00000589955.1 | Ensembl |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | ENST00000589955.1 | Ensembl |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | ENST00000589955.1 | Ensembl |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | ENST00000589955.1 | Ensembl |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | ENST00000589955.1 | Ensembl |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | ENST00000590515.1 | Ensembl |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | ENST00000590515.1 | Ensembl |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | NM_000633.2 | Refseq |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | NM_000633.2 | Refseq |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | NM_000633.2 | Refseq |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | NM_000633.2 | Refseq |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | NM_000633.2 | Refseq |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | NM_000633.2 | Refseq |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | NM_000633.2 | Refseq |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | NM_000633.2 | Refseq |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | NM_000633.2 | Refseq |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | NM_000657.2 | Refseq |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | NM_000657.2 | Refseq |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | NM_000657.2 | Refseq |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | NM_000657.2 | Refseq |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | NM_000657.2 | Refseq |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | NM_000657.2 | Refseq |
| Affymetrix Human Clariom D Assay | TC1800008891.hg.1 | NM_000657.2 | Refseq |
| Affymetrix Human Clariom D Assay | PSR1800161105.hg.1 | ENST00000589955.1 | Ensembl |
| Affymetrix Human Clariom D Assay | PSR1800161105.hg.1 | NM_000657.2 | Refseq |
| Affymetrix Human Clariom D Assay | PSR1800161105.hg.1 | TC1800008891.hg.1 | Clariom D TC |
| Affymetrix Human Clariom D Assay | PSR1800161105.hg.1 | ENST00000589955.1 | Ensembl |
| Affymetrix Human Clariom D Assay | PSR1800161105.hg.1 | NM_000657.2 | Refseq |
| Array Name | Probe IDs | Targets | Target Type |
|---|---|---|---|
| ABI Human Genome Survey Microarray Version 2.0 | 156671 | - | - |
Back To TopCitations (1)
Glycogen synthase kinase-3beta: a prognostic marker and a potential therapeutic target in human bladder cancer.
- Authors
- Naito S, Bilim V, Yuuki K, Ugolkov A, Motoyama T, Nagaoka A, Kato T, Tomita Y
- Journal
- Clin Cancer Res - Page No 5124 (Mon Nov 01 00:00:00 UTC 2010)
- Volume (Year)
- 16 (2010)
- Product Usage
- -
Back To Top